Drug Rebates and Discounts Amounted to $106 Billion in 2015

In a new report commissioned by industry group PhRMA, in 2015 drug companies collected less than half of the total money spent on prescription drugs in the U.S. Branded pharma reaped 47% while generics makers retained 23%, and “non-manufacturer stakeholders,” or the supply chain, kept 31%. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.